141 related articles for article (PubMed ID: 36527909)
1. Adverse outcomes of GHB use: Analysis of ambulance attendances in metropolitan and regional Victoria.
Ogeil RP; Faulkner A; Beard N; Killian JJ; Arunogiri S; Phan V; Wilson J; Smith K; Lubman DI; Scott D
Int J Drug Policy; 2023 Jan; 111():103932. PubMed ID: 36527909
[TBL] [Abstract][Full Text] [Related]
2. Trends in gamma-hydroxybutyrate-related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia.
Arunogiri S; Moayeri F; Crossin R; Killian JJ; Smith K; Scott D; Lubman DI
Addiction; 2020 Mar; 115(3):473-479. PubMed ID: 31618793
[TBL] [Abstract][Full Text] [Related]
3. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
Dietze PM; Cvetkovski S; Barratt MJ; Clemens S
Med J Aust; 2008 Jun; 188(12):709-11. PubMed ID: 18558893
[TBL] [Abstract][Full Text] [Related]
4. The Incidence and Temporal Patterns of Use of Amphetamine-Type Stimulant Use in Traffic-Related Ambulance Attendances From 2015 to 2020 in Victoria, Australia.
Hayley AC; Ogeil RP; Faulkner A; Beard N; Downey LA; Smith K; Lubman DI; Scott D
J Stud Alcohol Drugs; 2023 Jan; 84(1):128-136. PubMed ID: 36799683
[TBL] [Abstract][Full Text] [Related]
5. Aggression and violence at ambulance attendances where alcohol, illicit and/or pharmaceutical drugs were recorded: A 5-year study of ambulance records in Victoria, Australia.
Coomber K; Curtis A; Vandenberg B; Miller PG; Heilbronn C; Matthews S; Smith K; Wilson J; Moayeri F; Mayshak R; Lubman DI; Scott D
Drug Alcohol Depend; 2019 Dec; 205():107685. PubMed ID: 31704380
[TBL] [Abstract][Full Text] [Related]
6. Changes in alcohol intoxication-related ambulance attendances during COVID-19: How have government announcements and policies affected ambulance call outs?
Ogeil RP; Scott D; Faulkner A; Wilson J; Beard N; Smith K; Manning V; Lubman DI
Lancet Reg Health West Pac; 2021 Sep; 14():100222. PubMed ID: 34545354
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends and the effect of reformulation in Victoria, Australia from 2013 to 2018.
Nielsen S; Sanfilippo PG; Scott D; Lam T; Smith K; Lubman DI
Addiction; 2021 Aug; 116(8):2233-2241. PubMed ID: 33296537
[TBL] [Abstract][Full Text] [Related]
8. Opioid-related ambulance attendances during the first 2 years of the COVID-19 pandemic in Victoria, Australia.
McGrath M; Stare M; Chua P; Ogeil R; Nehme Z; Scott D; Lubman DI
Addiction; 2024 Feb; 119(2):348-355. PubMed ID: 37816493
[TBL] [Abstract][Full Text] [Related]
9. Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances.
Heilbronn C; Lloyd B; McElwee P; Eade A; Lubman DI
Drug Alcohol Rev; 2013 Jul; 32(4):405-11. PubMed ID: 23350582
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances.
Crossin R; Scott D; Arunogiri S; Smith K; Dietze PM; Lubman DI
Med J Aust; 2019 Feb; 210(2):75-79. PubMed ID: 30712302
[TBL] [Abstract][Full Text] [Related]
11. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
12. Hospital in the field: prehospital management of GHB intoxication by medical assistance teams.
Dutch MJ; Austin KB
Prehosp Disaster Med; 2012 Oct; 27(5):463-7. PubMed ID: 22809488
[TBL] [Abstract][Full Text] [Related]
13. Trends in cannabis-related ambulance presentations from 2000 to 2013 in Melbourne, Australia.
Kaar SJ; Gao CX; Lloyd B; Smith K; Lubman DI
Drug Alcohol Depend; 2015 Oct; 155():24-30. PubMed ID: 26361711
[TBL] [Abstract][Full Text] [Related]
14. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne.
Lloyd BK; McElwee PR
Drug Alcohol Rev; 2011 May; 30(3):271-80. PubMed ID: 21545557
[TBL] [Abstract][Full Text] [Related]
15. Gamma-hydroxybutyrate: a 30 month emergency department review.
Munir VL; Hutton JE; Harney JP; Buykx P; Weiland TJ; Dent AW
Emerg Med Australas; 2008 Dec; 20(6):521-30. PubMed ID: 19125832
[TBL] [Abstract][Full Text] [Related]
16. Commentary on Arunogiri et al. (2020): Findings from surveillance of patterns of drug use and related harms need careful interpretation, promotion and response.
Dietze P; Horyniak D
Addiction; 2020 Mar; 115(3):480-481. PubMed ID: 31849134
[No Abstract] [Full Text] [Related]
17. The incidence and characteristics of volatile substance use related ambulance attendances in metropolitan Melbourne, Australia.
Cvetkovski S; Dietze P
Soc Sci Med; 2008 Feb; 66(3):776-83. PubMed ID: 18023515
[TBL] [Abstract][Full Text] [Related]
18. Adolescent Suicidal Behaviors During the COVID-19 Pandemic in Australia: Analysis of Acute Harms Assessed via Ambulance Data.
Scott D; McGrath M; Beard N; Chislett S; Baldwin R; Nehme Z; Lubman DI; Ogeil RP
J Adolesc Health; 2024 May; 74(5):908-915. PubMed ID: 38340123
[TBL] [Abstract][Full Text] [Related]
19. Changes in demand for emergency ambulances during a nationwide lockdown that resulted in elimination of COVID-19: an observational study from New Zealand.
Dicker B; Swain A; Todd VF; Tunnage B; McConachy E; Drake H; Brett M; Spearing D; Howie GJ
BMJ Open; 2020 Dec; 10(12):e044726. PubMed ID: 33361171
[TBL] [Abstract][Full Text] [Related]
20. Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
Nielsen S; Dietze P; Cantwell K; Lee N; Taylor D
J Subst Abuse Treat; 2008 Dec; 35(4):457-61. PubMed ID: 18295435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
